CLINICAL TRAIL OF IV ETOPOSIDE, CARBOPLATIN AND CYCLOPHOSPHAMIDE COMBINATION CHEMOTHERAPY AGAINST PERSISTENT OR RECURRENT OVARIAN CANCER AS 2ND OR MORE LINE CHEMOTHERAPY
CLINICAL TRAIL OF IV ETOPOSIDE, CARBOPLATIN AND CYCLOPHOSPHAMIDE COMBINATION CHEMOTHERAPY AGAINST PERSISTENT OR RECURRENT OVARIAN CANCER AS 2ND OR MORE LINE CHEMOTHERAPY